Anaplastic Oligoastrocytoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Anaplastic Oligoastrocytoma

subtype

Identifier: CI-CAN-00000446
Entity page: /cancer/anaplastic-oligoastrocytoma ↗
Edges: 52

Neighbours: 14 drugs10 trials
Drawn: 24 of 24 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Anaplastic Oligoastrocytoma investigated in trials for …INVESTIGATED_IN_TRIALSderived14 of 14
→ investigated in trials for	Temozolomidesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Anaplastic Oligoastrocytoma	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Carmustinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants

Anaplastic Oligoastrocytoma studied in …STUDIED_INderived10 of 38show all (up to 200)
→ studied in	NCT03180502Phase 2 · active not recruiting Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04623931Phase 2 · recruiting Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02192359Phase 1 · active not recruiting Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02800486Phase 2 · recruiting Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01849952terminated Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02026271Phase 1 · completed A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03043391Phase 1 · completed Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01922076Phase 1 · completed Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02168270Phase 1 · terminated Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01721577Phase 1/Phase 2 · terminated Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas · condition mapped CURATED_BROADER · 38 trials mapped (4 active)	—	—	Anaplastic Oligoastrocytoma	1	Observed	clinicaltrials	graph →